Myricetin suppresses UVB-induced skin cancer by targeting Fyn

Keyphrases

• Skin Cancer 100%
• Ultraviolet-B (UV-B) 100%
• Myricetin 100%
• Kinase Activity 27%
• Mouse Skin 27%
• Fyn Kinase 27%
• Chemopreventive 18%
• Cyclooxygenase-2 Expression 18%
• Human Cancer 9%
• Anticancer 9%
• Amino 9%
• Epidermis 9%
• Phosphorylation 9%
• Pullout 9%
• Phytochemicals 9%
• Pharmacological Inhibitors 9%
• Kinase Assay 9%
• Inhibitory Effect 9%
• Dose Effect 9%
• Tert-butyl 9%
• Mitogen-activated Protein Kinase 9%
• Skin Tumor 9%
• Activator protein-1 (AP-1) 9%
• Western Blot Assay 9%
• Phenyl 9%
• JB6 Cells 9%
• Kinase Domain 9%
• 1-factor 9%
• Nuclear factor-B 9%
• Red Wine 9%
• Most Common Form 9%
• Tumor Incidence 9%
• Chloro 9%
• Skin Carcinogenesis 9%
• N-lobe 9%
• C-lobe 9%
• Assay Data 9%
• ATP Binding Site 9%
• Pyrazolo 9%
• Skin Tumorigenesis 9%
• In Vivo Mice 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Skin Cancer 100%
• Myricetin 100%
• Protein Kinase Fyn 27%
• Phosphotransferase 18%
• Cyclooxygenase 2 18%
• Adenosine Triphosphate 18%
• Western Blot 9%
• Malignant Neoplasm 9%
• Binding Site 9%
• Cancer Incidence 9%
• Skin Tumor 9%
• Alternative Complement Pathway C3 C5 Convertase 9%
• Mitogen Activated Protein Kinase 9%
• Transcription Factor AP 1 9%
• Nuclear Factor 9%
• Phytochemical 9%
• Skin Carcinogenesis 9%
• Carcinogenesis 9%